Microsoft’s Gen-AI Outpaces Azure in CapEx Efficiency, Says Goldmanby Mark Eisenberg 25.06.2024"Microsoft's Gen-AI investments yield high capital efficiency, with AI revenue growth surpassing early Azure benchmarks, per Goldman Sachs."
Bitcoin’s Supply in Profit Drops Amid Post-Halving Effectsby John Darbie 25.06.2024Bitcoin’s supply in profit drops to 80% post-halving, reflecting market changes. Key historical data and recent trends offer vital investment ...
Bitcoin Nears $60K Amid Mt. Gox Payout Concernsby John Darbie 25.06.2024Bitcoin drops amid Mt. Gox payout news. Market fears minimal with fewer BTC expected for sale. Long-term holders may stabilize ...
UBS Predicts Tesla Will Miss Q2 Delivery Targets by 25,000by Mark Eisenberg 25.06.2024UBS forecasts Tesla will miss Q2 2023 delivery targets by 25,000 vehicles, with 420,000 expected, impacting gross margins and stock ...
“Shiba Shootout Surge: New Meme Coin Gains Momentum”by John Darbie 24.06.2024Shiba Shootout gains traction as Pepe and Doge prices dip. Shiba Shootout's Wild West theme and high staking rewards draw ...
Tech Sector Weakness Drags S&P 500 and Nasdaq Lowerby Lilu Anderson 22.06.2024Tech sector dip pulls S&P 500 and Nasdaq; Nvidia drops over 3%, marking significant impact. Dow ends week up; US ...
EV Adoption Growth Slows, Incumbents Poised to Profitby Mark Eisenberg 22.06.2024"Bank of America's revised forecast shows slower EV growth with 25% adoption by 2027, hybrids gaining ground, and traditional automakers ...
Levi Strauss Maintains Buy Rating Amid Positive Market Sentimentby Mark Eisenberg 22.06.2024Levi Strauss stock holds a Buy rating from UBS at a $25 target. Stable investor sentiment, strategic growth moves, and ...
Memereum Sells 1M Tokens; Launches Innovative MemeSwapby John Darbie 22.06.2024Memereum sells over 1M tokens in hours, launches MemeSwap, offers 183% APY staking, and lists on major exchanges amid market ...
Zealand Pharma Surges on Promising Weight Loss Drug Trial Resultsby Mark Eisenberg 21.06.2024Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...